Elliot Cutler performed the first closed mitral commissurotomy (CMC) with a tenotomy knife on a 12 years old patient with rheumatic mitral stenosis in 1923. Despite initial enthusiasm, mortality rates were excessive and the procedure was abandoned in 1929. It was not until the late 1940s, that Harken and Bailey described the closed technique of mitral commissurotomy, which became the accepted surgical treatment for mitral stenosis.The primary mechanism of both is similar and involves a mechanical splitting of one or both mitral commissures.
For about last 16 years, the only treatment that was available for these patients was surgical commissurotomy, either open or closed.
Clearly, there will be difficulty in comparing the techniques since there are variabilities in the patient populations that undergo these procedures due to valve pathology and the use of patients from various countries; where the patient's ages and valve pathology are not the same as that seen with RHD in other countries.
We believe that despite the early success of mitral balloon valvuloplasty, it should remain in investigational technique at the current time. Surgical commissurotomy is a highly successful technique with a long record of experience, whereas the long term outcome of balloon valvuloplasty is not yet known and the rate of certain complications may be higher. In addition, the criteria for optimal patient selection for balloon mitral valvuloplasty is not yet known and the rate of certain complications may be higher. In addition, the criteria for optimal patient selection for balloon mitral valvuloplasty are still evolving and technical aspects of the procedure are changing. 1 
Materials and Methods

Study population
This prospective comparative study was carried on 60 patients in each group of symptomatic mitral stenosis, who attended the Department of Cardiology and Cardiovascular Surgery, during the period from January 1998 to July 1999 in the Department of Cardiology and Cardiovascular Surgery, National Institute of Cardiovascular Diseases (NICVD), Dhaka, Bangladesh.
Preprocedural evaluation
Echocardiography:
• Echo was done by one expert using 2.8/3.5 MHz convex transducer.
• Mitral valve area was calculated by planimetry method in short-axis view and also by pressure half-time(PHT) method.
• Mitral valve morphology was studied extensively by several methods.
• Mitral valve echo-score (Wilkins'score)were developed by Abascal et al.(1988) ( Table-1 ) and a score more than 10 were excluded.
• Only commissural morphology of mitral valve was studied considering fusion, thickness and calcification of the commissures by Fatkin et al. 2 • MR echo score by Padial et al. was developed to predict the development of mitral regurgitation as a complication of the procedures 3 .
• Mean and peak pressure gradients across the mitral valve were calculated using CW Doppler.
• Pulmonary artery systolic pressure (PASP) was measured considering the tricuspid regurgitation by CW Doppler.
• Colour flow imaging was done. Patients with >grade II MR, > grade II AR and significant aortic stenosis were excluded.
• 2D, M mode study: LA diameter was calculated and LV study was done, including LVEF% by POMBO method from M mode echocardiography.
• TEE was done before procedures in suspected cases of LA thrombus.
Procedure(PTMC and CMC) 1) PTMC was done with all aseptic precautions through femoral approach under local anaesthesia.
2) Following pressure studies were done during the procedure: aorta, LV, RV, PA and LA; LV/ LA gradient calculated.
3) A simple balloon sizing method based on body height for selection of appropriate size balloon catheter was used:
Height in cm Balloon size = + 10 10 4) CMC was done as closed heart surgery under general anaesthesia by skin incision through left 4th of 5th intercostal space. Transatrial finger fracture technique and transventricular commissurotomy technique using Tubbs' dilator were applied. 4 5) The width of Tubbs' dilator was set in advance in 3.0 to 3.5 cm for male and in 2.5 to 3.0 cm for female.
6) Any periprocedural complication was recorded.
Postprocerure evaluation 1) 2D, M mode, PW, CW Doppler and colour flow imaging were done iminediately after PTMC and within 7 ±3 days after CMC to evaluate all echocardiographic parameters, which were taken before the procedures.
2) Successful procedure was defined as increased in mitral valve area (MVA) to > 1.5 cm 2 or > 50 percent increase in MVA. 
Follow-up evaluation
Thickness of mitral leaflets:
All the patients had score within the range of 1 3 with no patient with score 0 and 4. Most of the patients (95 %) of both groups had score of 1 and 2 with no significant difference.
Subvalvular changes (SVC):
Most of the patients (75 %) had SVC of score 2 and 3. One patient of PTMC group had SVC score of 4.
Calcification: More than 55 percent patients of both groups had no calcification (score 0). Two patients of PTMC group had calcification score of 3. None had a score of 4. 
Outcome of procedures in the context of Echocardiographic mitral valve morphology
In our study, one important target was to observe the association between the preprocedural mitral valve morphology by different echo scoring system and postprocedural outcome of the two procedures, and also compare the different echo scoring system of mitral valve morphology with the postprocedural outcome. Distribution of two different echo-scores are statistically not significant between two groups but wellcorrelated between two echo-scoring systems (r = 0. 7 1) Both the total Wilkins' scores (< 6 vs ≥ 6) and total commissural morphology scores (good vs bad) were well correlated with postprocedural MVA (r = 0.71), but not with the preprocedural mitral valve area. 
Discussion
Although surgical closed mitral commissurotomy is an effective means for treating patients with mitral stenosis with suitable valve morphology and absent LA thrombus, it has come inherent limitation of its own. Dilating stenotic mitral valve by using balloon catheter introduced through venous route and transseptal puncture is an effective alternative to surgical closed mitral commissurotomy. Although started in early 1980s and being used widely throughout the world, Inoue balloon catheter system is the most popular and widely used method for PTMC. For appropriate selected patients, PTMC may be an cost effective alternative to CMC. Our study was aimed at to see the effectiveness of PTMC for treating patients with mitral stenosis compared to CMC in the context of favourable mitral valve morphology.
Comparison of outcome in the context of echocardiographic mitral valve morphology
Post et al. stated that total Wilkins' (MGH), echocardiographic scores were correlated with postprocedural outcome in both procedures significantly (P<0.001). 5 Subscores for leaflet mobility (P<0.001) and subvalvular disease (P<0.001) were highly correlated, but the subscores for valvular thickness (P=0.91) and calcification (P=0.29) did not correlate.
Fatkin et al. 2 mentioned that commissural splitting is the dominant mechanism by which mitral valve area is increased with the Inoue balloon techniques and Tubbs' dilator, and it can be predicted by echocardiographic assessment of commissural morphology. Commissural morphology is a better predictor of outcome than is the total Wilkins' mitral valve echo score.
Padial et al. 3 mentioned that the new mitral regurgitation echocardiographic score can predict the development of severe mitral regurgitation after PTMC and can be useful in the selection of patients for this technique.In our findings also showed similar results as the above mentioned papers, but did not 
Short term follow up results
Our patients had been followed for a short period of 22 ± 6 weeks due to some unavoidable limitations. All the patients of our initial series (n=60) were supposed to be followed up for at least 24 weeks in this study. But all the patients could not turn up timely at follow up. Our mean follow up time was 22 ± 6 weeks. There was no significant reduction of mitral valve area at follow up (1.94+0.24 vs 1.90+0.27 cm 2 ). mean pressure gradient also remained stable during this period (mean+SD = 5.60+2.09 mmHg). About 90 percent of the patients of both the groups had remained NYHA class I and II. All the patients at follow up reported significant subjective improvement in their exercise capacity and quality of life. Our findings are well in keeping with other relatively short term follow up reports. 6, 7 Repeat cardiac catheterization was not done to document persistent haemodynamic improvement at follow up in our study. One of the most common predictors of immediate outcome is echocardiographic score and calcification of mitral valve. In our study, we tried to find out whether any baseline variable or variables has strong association with the postprocedural outcome of PTMC and CMC. Our baseline variables were age < 35 years and ≥ 35 years, sex (M/F), total echo score (<6 and ≥ 6), baseline good (score 0 1) vs bad (score 2 3), commissural morphology score and total MR echo score (<5 vs ≥ 5 score as good vs bad) and preprocedural MVA (≤ 0. 07 and ≥ 0. 7 cm 2 ). Our dependable variables were increase in MVA, decrease in MPG, PPG, PASP, decrease in LA size and occurrence/worsening of MR grade. By statistical analysis, we found total MV score to be strongly associated with postprocedural outcome in terms of decrease in MPG< increase in MVA and occurrence/worsening of MR (P<0.001) in individual group but there was no significant difference of outcome regarding baseline variables between the two procedures. All these findings are similar as reported in other studies. 11, 12 Otherwise, like many other international studies, we found total echo score to most strongly influence the post PTMC outcome.
Other factors, we found to influence different dependent variables of the procedure were age, commissural morphology score and MR score. All these findings are well consistent with other studies.
Conclusion:
In contrast to surgical closed mitral commissurotorny (CMC), percutaneous transvenous mitral commissurotomy (PTMC) produce excellent and comparable early clinical and haernodynarnic improvement that is sustained through mid-term period of follow-up. However, the good results, simplicity of procedure, short hospital staying, better patient acceptance and elimination of drawbacks of thoracotomy and general anaesthesia indicate that PTMC should be the treatment of choice for patients with tight pliable rheumatic mitral stenosis.
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